StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.14−0.15 (-1.13%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Ascentage Pharma Group International enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Ascentage Pharma Group International's enterprise value was $1.52B on Nov 11, 2026, against $2.68B a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.52B-30.4%
2025Dec 31, 2025$2.18B–

More Ascentage Pharma Group International figures

See a number that looks wrong?